drugset / Trial / NCT05829603
Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects
RandomizedParallel-groupSingle-blindOther
Summary
The goal of this clinical trial is to compare corresponding inter- and intraindividual pharmacokinetic and pharmacodynamic profiles including assessments of safety \& tolerability.
Timeline
- Start
- 2023-05-05
- Primary completion
- 2023-09-17
- Completion
- 2023-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dimethyltryptamin | Unknown | — | — |
| Subject | Harmine | Small molecule | — | — |
Indications
No indication recorded.